The development of more specific biomarkers for prostate cancer and/or high‐risk prostate
cancer is necessary, because the prostate‐specific antigen test lacks specificity for the …

Prostate cancer is the most frequently diagnosed malignancy in American men, and a more
aggressive form of the disease is particularly prevalent among African Americans. The …

Background Lipids have critical functions in cellular energy storage, structure and signaling.
Many individual lipid molecules have been associated with the evolution of prostate cancer; …

The development of biomarkers for prostate cancer screening, detection, and
prognostication has revolutionized the management of this disease. Prostate-specific …

Background ETS transcription factors regulate important signaling pathways involved in cell
differentiation and development in many tissues and have emerged as important players in …

Background: Early detection of prostate cancer (CaP), the most prevalent cancer and the
second-leading cause of death in men, has proved difficult, and current detection methods …

Background Prostate cancer is the most common cancer in American men that ranges from
low risk states amenable to active surveillance to high-risk states that can be lethal …

Prostate cancer remains the second‐most common cancer diagnosed in men, despite the
increasingly widespread use of serum prostate‐specific antigen (PSA) screening. The …

Only 30% of patients with elevated serum prostate specific antigen (PSA) levels who
undergo prostate biopsy are diagnosed with prostate cancer (PCa). Novel methods are …

The deficiencies of serum PSA as a prostate-cancer-specific diagnostic test are well
recognized. Thus, the development of novel biomarkers for prostate cancer detection …